Attention deficit hyperactivity disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Conform to the diagnostic criteria for attention deficit hyperactivity disorder in Western Medicine; (2) Conforms to Qi and Yin deficiency syndrome of traditional Chinese medical differentiation standard; (3) The hyperactivity index of Conners scale is more than 1.5; (4) Aged 6 to 14 years old; (5) In the past two weeks without any psychoactive substances such as JingLing liquid,Pediatric HuangLong granule, Pemoline, Amphetamine, Cylert, Imipramine and other stimulants or tricyclic antidepressants; (6) Signed the informed consent,and voluntary take part in trial. The process of obtaining informed consent should comply with GCP regulations.
Exclusion criteria
Exclusion criteria: (1) With serious organic diseases of cardiovascular,hepatic,renal,hematopoietic and nervous system,such as chronic nephritis,hepatitis,congenital heart disease,infantile chorea,subacute encephalitis; (2) The symptoms of hearing impaired children are similar with attention deficit hyperactivity disorder; (3) The symptoms of mental retardatd children are similar with attention deficit hyperactivity disorder; (4) The symptoms of normai growing development children are similar with attention deficit hyperactivity disorder; (5) The diseases are similar with attention deficit hyperactivity disorder,such as fragile X syndrome, phenylketonuria, etc.; (6) Tourette syndrome; (7) Failure to complete the use of drugs, can not determine the efficacy or incompleted datas affect the efficacy or safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Digital Video EEG;Neuro Biochemistry; | — |
Secondary
| Measure | Time frame |
|---|---|
| Routine Blood Test;Routine Urine Test;Biochemistry;Electrocardiogram; | — |
Countries
China
Contacts
Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine